Prelude Therapeutics Inc

The current institutional shareholding score of Prelude Therapeutics Inc is 5.00, ranking 132 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 57.50%, representing a quarter-over-quarter increase of 4.23%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.33% of shares outstanding, with 22.15% decrease in holdings.